Bang & Olufsen’s Medicom has just announced an introduction of LEVA® disposable subQ injector that features a skin sensor and an automatic needle retraction for safety:
From the statement released to the press:
As treatment settings are changing, more patients are undertaking self-administrative medication. An increasing number of patients need the assistance of hand-held drug delivery systems, and as the need for injectable medication is anticipated to grow rapidly in the future, the demand for easy to use and safe injection devices will rise (Dubin, C. in Drug Delivery Technology, Sept. 07).
Who knows better what the users want than themselves? When creating LEVA®, we asked patients, nurses and doctors about their needs and preferences in order to provide a state of the art injection solution with safety and ease of use in focus. This provides a profound insight of the crucial features for the users and a special attention to how to obtain better patient compliance.
LEVA® has been created with focus on safety, which is reflected in the automatic needle retraction, shielding the needle permanently, and the skin sensor, avoiding unintended dose releases. Furthermore, the inspection window allows for easy dose confirmation both before and after the injection. After use, the device can safely be disposed of, since the needle is shielded inside the device, and the needle is never visible to the user.
Moreover, LEVA® is disposable and designed for subcutaneous injections of fixed doses, which results in a device that requires only a minimum of user steps, this makes the device accessible for a wide spectrum of patients. The ergonomic, non-medical design and the functionalities of the device are fully customisable for individual requirements.